Chemotherapy-Induced Endothelial Dysfunction: a Bibliometric Analysis of Research Trends from 1994 to 2024

Chemotherapy-induced endothelial damage is a complex issue characterized by cardiovascular toxicity and cellular injury.<br /> This <b>study aims</b> to analyze primary research areas related to chemotherapy-induced endothelial dysfunction, focusing on countries, institutions, journals, authors, and keywords.  <br /> <b>Methods.</b> The research employs a descriptive bibliometric design to collect and analyze data from 3,430 publications indexed in the Web of Science and Scopus databases, spanning the years 1994-2024. The bibliometric analysis includes English-language research articles and review papers examining endothelial dysfunction in chemotherapy patients. Data analysis was conducted using RStudio and the Bibliometrix R package, with VOSviewer utilized for visualization.<br /> <b>Results</b><b>.</b> The annual publication trend reveals fluctuations, peaking in 2005 while showing sustained interest in recent years. The United States leads in publication volume with 1,328 articles, closely followed by China and Japan. High levels of international collaboration were noted, particularly between the United States and European countries. Key contributing institutions include Harvard Medical School in the USA and the National Cancer Institute, while prominent authors such as Wang and Kim make significant contributions to the field. "Cancer Research" is recognized as one of the most influential journals, highlighting the interdisciplinary relevance of this field.<br /> <b>Conclusions.</b> This bibliometric analysis highlights the evolving key research trends related to angiogenesis, VEGF inhibitors, and the need to increase international cooperation. Given the recent introduction of new classes and groups of chemotherapeutic drugs into practice and the growing body of knowledge in this area, a renewed surge of interest in this topic can be anticipated.